UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

RECOVERY OF LEFT VENTRICLE FUNCTION WITH MEDICAL THERAPY IN DCM PATIENTS WITH TITIN MUTATIONS

Canadian journal of cardiology, 2016-10, Vol.32 (10), p.S71-S72

2016

Volltextzugriff (PDF)

P253 Withdrawal of beta- blockers and ACE inhibitors after left ventricular systolic function recovery in patient with dilated cardiomyopathy randomized control trial

European heart journal, 2020-01, Vol.41 (Supplement_1)

2020

Volltextzugriff (PDF)

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)

Journal of the American College of Cardiology, 2000-01, Vol.35 (1), p.60-66

2000

Volltextzugriff (PDF)

Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients

Transplantation, 1999-12, Vol.68 (12), p.1839

1999

Volltextzugriff (PDF)

The molecular genetics of hypertrophic cardiomyopathy

Current opinion in cardiology, 1995-05, Vol.10 (3), p.293-298

Elstein, Eleanor

1995

Volltextzugriff (PDF)

Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction

Transplantation proceedings, 2000-03, Vol.32 (2), p.446-448

2000

Volltextzugriff (PDF)

Polymorphisms in genes of angiotensin converting enzyme, angiotensinogen, nitric oxide synthase, and endothelin and their association with cardiac allograft rejection

Transplantation proceedings, 1997-09, Vol.29 (6), p.2576-2576

1997

Volltextzugriff (PDF)

Polymorphisms for angiotensin converting enzyme, angiotensinogen, nitric oxide synthase, and endothelin and their association with cardiac allograft vasculopathy in the first year posttransplant

Transplantation proceedings, 1997-09, Vol.29 (6), p.2575-2575

1997

Volltextzugriff (PDF)

C677T gene mutation in methylenetetrahydrofolate reductase as a risk factor for cardiac allograft vasculopathy

Transplantation proceedings, 1999-02, Vol.31 (1-2), p.99-99

1999

Volltextzugriff (PDF)

Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : The randomized evaluation of strategies for left ventricular dysfunction pilot study

Circulation (New York, N.Y.), 2000-02, Vol.101 (4), p.378-384

2000

Volltextzugriff (PDF)

Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy

Clinical transplantation, 1998-06, Vol.12 (3), p.243-249

1998

Volltextzugriff (PDF)

Results of an Open One-Year Study with Diane-35 in Women with Polycystic Ovarian Syndrome

Annals of the New York Academy of Sciences, 1993-05, Vol.687 (1), p.263-271

1993

Volltextzugriff (PDF)

Optimal timing for surveillance endomyocardial biopsies in heart transplant patients receiving antithymocyte globulin induction

Transplantation proceedings, 1999-02, Vol.31 (1-2), p.79-79

1999

Volltextzugriff (PDF)

Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy

Journal of investigative medicine, 1997-12, Vol.45 (9), p.542

1997

Volltextzugriff (PDF)

Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors

Canadian Medical Association journal, 1999-08, Vol.161 (3), p.255

1999

Volltextzugriff (PDF)

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). Commentary

Journal of the American College of Cardiology, 2000, Vol.35 (1), p.60-70

2000

Volltextzugriff (PDF)

Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use

Pharmacoepidemiology and drug safety, 2001-06, Vol.10 (4), p.287-294

2001

Volltextzugriff (PDF)

Polymorphisms for angiotensin converting enzyme, angiotensinogen, nitric oxide synthase, and endothelin and their association with cardiac allograft vasculopathy in the first year posttransplant : Transplant arteriosclerosis-Chronic rejection

Transplantation proceedings, 1997, Vol.29 (6)

1997

Volltextzugriff (PDF)

Polymorphisms in genes of angiotensin converting enzyme, angiotensinogen, nitric oxide synthase, and endothelin and their association with cardiac allograft rejection : Transplant arteriosclerosis-Chronic rejection

Transplantation proceedings, 1997, Vol.29 (6)

1997

Volltextzugriff (PDF)

CLINICAL BENEFIT OF NEORAL DOSE MONITORING WITH CYCLOSPORINE 2-HR POST-DOSE LEVELS COMPARED TO TROUGH LEVELS IN STABLE HEART TRANSPLANT PATIENTS

Transplantation, 1999-04, Vol.67 (7), p.S24

1999

Volltextzugriff (PDF)

PREDICTORS OF LONG-TERM RENAL FUNCTION AFTER HEART TRANSPLANTATION

Transplantation, 1999-04, Vol.67 (7), p.S108

1999

Volltextzugriff (PDF)

NEORAL DOSE MONITORING WITH 2 HOUR POST-DOSE LEVELS IN HEART TRANSPLANT PATIENTS RECEIVING ANTITHYMOCYTE GLOBULIN INDUCTION: A PILOT STUDY

Transplantation, 1998-06, Vol.65 (12), p.S158

1998

Volltextzugriff (PDF)

NEORAL DOSE MONITORING WITH 2 HOUR POST-DOSE LEVELS IN HEART TRANSPLANT PATIENTS RECEIVING ANTITHYMOCYTE GLOBULIN INDUCTION: A PILOT STUDY

Transplantation, 1998-05, Vol.65 (Supplement), p.234

1998

Volltextzugriff (PDF)

Clinical benefit of neoral dose monitoring with cyclosporine 2-hour peak levels compared to trough levels in stable heart transplant patients

The Journal of heart and lung transplantation, 1999, Vol.18 (1), p.78-78

1999

Volltextzugriff (PDF)

The genetic basis of hypertrophic cardiomyopathy

Journal of molecular and cellular cardiology, 1992-12, Vol.24 (12), p.1471-1477

1992

Volltextzugriff (PDF)

1 – 25 von 243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(185)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

RECOVERY OF LEFT VENTRICLE FUNCTION WITH MEDICAL THERAPY IN DCM PATIENTS WITH TITIN MUTATIONS

P253 Withdrawal of beta- blockers and ACE inhibitors after left ventricular systolic function recovery in patient with dilated cardiomyopathy randomized control trial

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)

Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients

The molecular genetics of hypertrophic cardiomyopathy

Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction

Polymorphisms in genes of angiotensin converting enzyme, angiotensinogen, nitric oxide synthase, and endothelin and their association with cardiac allograft rejection

Polymorphisms for angiotensin converting enzyme, angiotensinogen, nitric oxide synthase, and endothelin and their association with cardiac allograft vasculopathy in the first year posttransplant

C677T gene mutation in methylenetetrahydrofolate reductase as a risk factor for cardiac allograft vasculopathy

Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : The randomized evaluation of strategies for left ventricular dysfunction pilot study

Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy

Results of an Open One-Year Study with Diane-35 in Women with Polycystic Ovarian Syndrome

Optimal timing for surveillance endomyocardial biopsies in heart transplant patients receiving antithymocyte globulin induction

Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy

Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). Commentary

Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use

Polymorphisms for angiotensin converting enzyme, angiotensinogen, nitric oxide synthase, and endothelin and their association with cardiac allograft vasculopathy in the first year posttransplant : Transplant arteriosclerosis-Chronic rejection

Polymorphisms in genes of angiotensin converting enzyme, angiotensinogen, nitric oxide synthase, and endothelin and their association with cardiac allograft rejection : Transplant arteriosclerosis-Chronic rejection

CLINICAL BENEFIT OF NEORAL DOSE MONITORING WITH CYCLOSPORINE 2-HR POST-DOSE LEVELS COMPARED TO TROUGH LEVELS IN STABLE HEART TRANSPLANT PATIENTS

PREDICTORS OF LONG-TERM RENAL FUNCTION AFTER HEART TRANSPLANTATION

NEORAL DOSE MONITORING WITH 2 HOUR POST-DOSE LEVELS IN HEART TRANSPLANT PATIENTS RECEIVING ANTITHYMOCYTE GLOBULIN INDUCTION: A PILOT STUDY

NEORAL DOSE MONITORING WITH 2 HOUR POST-DOSE LEVELS IN HEART TRANSPLANT PATIENTS RECEIVING ANTITHYMOCYTE GLOBULIN INDUCTION: A PILOT STUDY

Clinical benefit of neoral dose monitoring with cyclosporine 2-hour peak levels compared to trough levels in stable heart transplant patients

The genetic basis of hypertrophic cardiomyopathy

Suchergebnisse filtern